KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginFCF Payout RatioGross MarginInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on Sales

AbbVie (ABBV) Debt to Equity (2016 - 2025)

Historic Debt to Equity for AbbVie (ABBV) over the last 14 years, with Q3 2025 value amounting to -$25.27.

  • AbbVie's Debt to Equity fell 31582.86% to -$25.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$25.27, marking a year-over-year decrease of 31582.86%. This contributed to the annual value of $19.96 for FY2024, which is 24944.8% up from last year.
  • Latest data reveals that AbbVie reported Debt to Equity of -$25.27 as of Q3 2025, which was down 31582.86% from -$470.72 recorded in Q2 2025.
  • AbbVie's 5-year Debt to Equity high stood at $46.71 for Q1 2025, and its period low was -$470.72 during Q2 2025.
  • Its 5-year average for Debt to Equity is -$17.73, with a median of $5.01 in 2023.
  • Examining YoY changes over the last 5 years, AbbVie's Debt to Equity showed a top increase of 40799.79% in 2025 and a maximum decrease of 464563.43% in 2025.
  • AbbVie's Debt to Equity (Quarter) stood at $4.97 in 2021, then fell by 26.31% to $3.66 in 2022, then soared by 56.06% to $5.71 in 2023, then skyrocketed by 249.45% to $19.96 in 2024, then plummeted by 226.6% to -$25.27 in 2025.
  • Its last three reported values are -$25.27 in Q3 2025, -$470.72 for Q2 2025, and $46.71 during Q1 2025.